BOB (psychedelic)
![]() | |
![]() | |
Names | |
---|---|
Preferred IUPAC name 2-(4-Bromo-2,5-dimethoxyphenyl)-2-methoxyethan-1-amine | |
Other names 4-Bromo-2,5,β-trimethoxyphenethylamine 2-(4-Bromo-2,5,β-trimethoxyphenyl)ethanamine | |
Identifiers | |
3D model (JSmol) | |
ChEMBL | |
ChemSpider |
|
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
| |
| |
Properties | |
C11H16BrNO3 | |
Molar mass | 290.157 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Chemical compound
BOB, also known as 4-bromo-2,5,β-trimethoxyphenethylamine, is a lesser-known psychedelic drug of the phenethylamine and BOx families. It is the β-methoxy analogue of 2C-B. BOB was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 10 to 20 mg, and the duration listed as 10 to 20 hours.[1] BOB produces an altered state of consciousness, tinnitus, a pleasant tingling throughout the body, and a sense of awareness.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of BOB.
Legal status
[edit]United Kingdom
[edit]This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[2]
See also
[edit]External links
[edit]References
[edit]- ^ a b BOB Entry in PiHKAL
- ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
Phenethylamines |
| ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amphetamines |
| ||||||||||||||||
Phentermines |
| ||||||||||||||||
Cathinones |
| ||||||||||||||||
Phenylisobutylamines (and further-extended) | |||||||||||||||||
Catecholamines (and close relatives) |
| ||||||||||||||||
Cyclized phenethylamines |
| ||||||||||||||||
Related compounds |
| ||||||||||||||||
![]() | This psychoactive drug-related article is a stub. You can help Wikipedia by expanding it. |